Cytek Biosciences (CTKB) Shareholder's Equity (2020 - 2026)

Cytek Biosciences (CTKB) Shareholder's Equity (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shareholder's Equity (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	52.06 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	22.98 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	49.20 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	26.10 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	10.33 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	13.34 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	2.96 Bn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	10.67 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	7.20 Bn
10	Cytek Biosciences	-	-	21.25 Mn	327.64 Mn

Download Data